mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.23 |
0.0005 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0005 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0005 |